Europe Animal Parasiticides Market Overview
The Europe animal parasiticides market was valued at USD 4.00 billion in 2025 and is projected to reach USD 6.71 billion by 2033, growing at a CAGR of 6.85% from 2026 to 2033. The market is supported by sustained demand for preventive and therapeutic parasite control across companion and farm animals, increasing awareness of zoonotic parasite risks, and the continued development of convenient topical, oral, and combination parasiticide products.
Europe represents a mature animal-health market with a broad veterinary infrastructure, established pharmaceutical manufacturers, and a large companion-animal population. Fleas, ticks, mites, and intestinal worms remain important parasite-control targets, while climate variability, cross-border animal movement, and travel can contribute to changing parasite exposure patterns. AnimalhealthEurope identifies parasite control as a cornerstone of veterinary care and notes that parasites can affect both animal and human health.
Key Market Trends & Insights
- Germany dominated the Europe animal parasiticides market with the largest revenue share of 21.66% in 2025, supported by supported by its well-established veterinary healthcare infrastructure, high demand for companion-animal healthcare, strong adoption of preventive parasite-control products, and the presence of leading animal health companies and veterinary pharmaceutical manufacturers.
- The ectoparasiticides segment dominated the Europe animal parasiticides market with a 49.25% share in 2026, supported by continued demand for flea and tick control products across companion and farm animals.
- Turkey is expected to be the fastest-growing region at a CAGR of 8.00% from 2026 to 2033, fueled by a growing companion animal population, increasing awareness of preventive veterinary care, rising demand for flea and tick control products, and expanding access to veterinary healthcare and animal health products.
- The Others segment within drug class dominated with a 58.32% share in 2025, while the carbamates segment is projected to register the fastest growth at a CAGR of 7.69% from 2026 to 2033.
- Prescription products dominated the mode of purchase category with a 63.10% share in 2025, reflecting the important role of veterinary diagnosis, treatment recommendations, and prescription-based parasite control.
- Branded products accounted for the largest drug type share at 62.59% in 2025, while generic products are expected to grow faster at a CAGR of 7.14% through 2033.
- Topical products led the route of administration category with a 42.10% share in 2025, whereas oral products are expected to record the fastest CAGR of 7.25% from 2026 to 2033.
Market Size & Forecast
- Market Value (2025): USD 4.00 Billion
- Expected Market Value (2033): USD 6.71 Billion
- Forecast CAGR (2026–2033): 6.85%
- Leading Region in 2025: Germany
- Fastest Growing Region: Turkey
Report Scope and Europe Animal Parasiticides Market Segmentation
|
Attributes |
Animal Parasiticides Key Market Insights |
|
Segments Covered |
|
|
Countries Covered |
|
|
Key Market Players |
|
|
Market Opportunities |
|
|
Value Added Data Infosets |
In addition to the insights on market scenarios such as market value, growth rate, segmentation, geographical coverage, and major players, the market reports curated by the Data Bridge Market Research also include in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework |
Europe Animal Parasiticides Market Trends
Trend: Growth in Demand for Novel Biological and Low-Chemical Residue Parasiticide Solutions
The increasing focus on sustainable animal healthcare practices is creating opportunities for the development of novel biological and low-chemical residue parasiticide solutions. Growing awareness regarding environmental impacts, chemical residues, and the need for safer parasite control approaches is encouraging manufacturers to explore alternative solutions that provide effective parasite management while reducing potential risks to animals, humans, and ecosystems. This shift is driving innovation toward advanced formulations with improved safety profiles and sustainable characteristics.
The rising preference for responsible livestock production and eco-conscious companion animal care is further supporting opportunities for companies to develop next-generation parasiticide products. Biological approaches, naturally derived active ingredients, and low-residue formulations can help address evolving regulatory expectations and consumer preferences for safer animal healthcare solutions. As the animal health industry moves toward more sustainable disease prevention strategies, the development of environmentally compatible parasiticides is expected to create new growth opportunities for market participants.
For instances,
-
In October 2025, the U.S. Department of Agriculture (USDA) APHIS highlighted biological control approaches as environmentally sound pest management methods that can reduce dependence on conventional chemical pesticides. The agency emphasized the use of natural biological agents as targeted control solutions within integrated pest management programs.
Europe Animal Parasiticides Market Dynamics
Key Market Driver: Increasing Burden of Vector-Borne Parasites Affecting Animal Health
The rising occurrence of vector-borne parasites, including ticks, fleas, mites, and other external parasites, is becoming a significant concern for companion animals and livestock populations. These parasites can negatively impact animal health by causing skin disorders, infections, irritation, reduced immunity, and transmission of various diseases. Increasing exposure of animals to parasite-prone environments, including farms, rural areas, and outdoor habitats, is contributing to greater demand for effective parasite control solutions.
The growing focus on maintaining animal welfare and preventing parasite-related health issues is encouraging the adoption of animal parasiticides across veterinary and agricultural applications. Livestock producers are increasingly prioritizing parasite management to minimize health complications and maintain animal productivity, while pet owners are becoming more proactive toward routine parasite prevention. This shift toward preventive animal healthcare practices is supporting the increased utilization of parasiticide products for controlling vector-borne parasite infestations.
For instance,
-
As reported by the World Organisation for Animal Health (WOAH) in May 2024, vector-borne diseases are emerging as a significant threat to animal health, with vectors such as ticks, mosquitoes, and flies contributing to the spread of diseases among animals. The organization highlighted that changing environmental conditions are influencing vector distribution and increasing the requirement for improved surveillance and control measures for animal health protection.
Key Restraint/Challenge: Development of Parasite Resistance Against Commonly Used Active Ingredients
The increasing development of parasite resistance against commonly used active ingredients is emerging as a significant restraint for the global animal parasiticides market. Repeated and improper use of certain antiparasitic compounds can reduce their effectiveness over time, allowing resistant parasite populations to survive and continue affecting animal health. Resistance among internal and external parasites, including worms, ticks, and other ectoparasites, creates challenges for veterinarians, farmers, and pet owners in maintaining effective parasite control programs.
The reduced response to existing parasiticide treatments is increasing the complexity of parasite management and encouraging the need for alternative control strategies, improved monitoring practices, and development of new active ingredients. Resistance issues can increase treatment costs, require frequent product rotation, and limit the effectiveness of established parasiticide solutions. As resistance continues to impact long-term parasite control efforts, it remains a key challenge that may restrict the broader adoption and effectiveness of conventional animal parasiticides.
For instance,
-
As reported by the U.S. Food and Drug Administration (FDA) in January 2026, concerns regarding antiparasitic resistance in livestock animals continue to require attention, with the agency emphasizing responsible use of approved antiparasitic products and veterinary oversight to maintain treatment effectiveness. The increasing recognition of resistance risks highlights challenges associated with maintaining long-term efficacy of existing parasiticide solutions.
Key Market Opportunity: Expansion of Online Veterinary Services and Digital Animal Healthcare Platforms
The increasing adoption of digital technologies in animal healthcare is creating new opportunities for improving access to veterinary services and parasite management solutions. Online veterinary consultations, digital health platforms, and remote monitoring tools are enabling pet owners and livestock producers to receive timely healthcare guidance, including recommendations for parasite prevention and treatment. These platforms are improving awareness regarding animal health practices and supporting early identification and management of parasite-related conditions.
The growing integration of technology into veterinary care is transforming traditional animal healthcare models by enhancing communication between veterinarians and animal owners. Digital platforms provide opportunities for personalized healthcare recommendations, medication guidance, and continuous monitoring, helping improve compliance with preventive parasite control programs. As digitalization continues to expand across the animal health sector, online veterinary services are expected to support wider adoption of animal parasiticides by improving accessibility and awareness.
For instances,
- As reported by Pet 24-7 Global Ltd in June 2026, the company launched its connected pet healthcare platform in India and Saudi Arabia, integrating digital health records, preventive care reminders, AI-based pet assistance, and veterinary support services. The platform enables pet owners to manage healthcare activities digitally and access veterinary guidance more conveniently.
Europe Animal Parasiticides Market Scope
The Europe animal parasiticides market is segmented on the basis of product, drug class, mode of purchase, drug type, route of administration, dosage form, disease type, animal type, end user, and distribution channel.
- By Product
On the basis of product, the market is segmented into ectoparasiticides, endoparasiticides, and endectocides. In 2026, the ectoparasiticides segment is expected to dominate the market with a market share of 49.28%, supported by demand for flea and tick control across companion and farm animals.
The endectocides segment is projected to register the fastest growth at a CAGR of 7.23% from 2026 to 2033, reflecting demand for products providing broader internal and external parasite coverage.
- By Drug Class
On the basis of drug class, the market is segmented into organochlorines, organophosphates, carbamates, benzimidazoles, imidazothiazoles, and others. In 2026, the others segment is expected to dominate with a market share of 58.22%.
The carbamates segment is expected to register the fastest growth in the Europe animal parasiticides market, expanding at a CAGR of 7.69% from 2026 to 2033, driven by increasing demand for effective parasite-control treatments and growing emphasis on preventive animal healthcare.
- By Mode of Purchase
On the basis of mode of purchase, the market is segmented into prescription and over the counter (OTC). In 2026, prescription products are expected to dominate with a market share of 63.23%, supported by veterinary diagnosis and professional treatment recommendations.
The prescription segment is projected to register the fastest CAGR of 7.07% from 2026 to 2033, mainly due to the increasing demand for prescription-based antiparasitic treatments, greater veterinary healthcare expenditure, and the growing prevalence of parasitic infections in animals.
- By Drug Type
On the basis of drug type, the market is segmented into branded and generic products. In 2026, branded products are expected to dominate with a market share of 62.49%, supported by established veterinary brands and product recognition.
The generic segment is expected to witness the fastest CAGR of 7.14% from 2026 to 2033, supported by growing demand for cost-effective treatment options, increasing preference for affordable alternatives to branded products, and the wider availability of generic antiparasitic drugs.
-
By Route of Administration
On the basis of route of administration, the market is segmented into topical, oral, injectables, and others. In 2026, topical products are expected to dominate with a market share of 42.03%, supported by their established use in ectoparasite control and convenient application.
The oral segment is expected to witness the fastest CAGR of 7.25% from 2026 to 2033, supported by the convenience of oral administration, ease of dosing, improved treatment compliance, and increasing adoption of systemic parasite-control products.
-
By Dosage Form
On the basis of dosage form, the market is segmented into solution, tablets, sprays, and others. In 2026, solution is expected to dominate with a market share of 43.68%, supported by the widespread use of topical and liquid parasite-control formulations.
The tablets segment is projected to record the fastest CAGR of 7.07% from 2026 to 2033, supported by convenient dosing, ease of administration, improved treatment compliance, and growing demand for oral parasite-control products.
-
By Disease Type
On the basis of disease type, the market is segmented into fleas, ticks, round worms, hookworms, ear mites, and others. In 2026, fleas are expected to dominate with a market share of 27.56%.
The ticks segment is expected to witness the fastest CAGR of 7.27% from 2026 to 2033, supported by the growing importance of tick-borne disease prevention, rising awareness of tick-related health risks, and changing parasite exposure pattern.
-
By Animal Type
On the basis of animal type, the market is segmented into companion animal and farm animals. In 2026, companion animals are expected to dominate with a market share of 75.51%, supported by high demand for routine flea, tick, and worm prevention in pets.
The farm animals segment is expected to witness the fastest CAGR of 7.27% from 2026 to 2033, supported by the rising prevalence of parasitic infections, increasing livestock populations, growing emphasis on animal health and productivity, and greater adoption of preventive parasite-control treatments.
-
By End User
On the basis of end user, the market is segmented into veterinary clinics, animal farms, home care, veterinary hospitals, pet shops, and others. In 2026, veterinary clinics are expected to dominate with a market share of 33.66%, reflecting their role in diagnosis, prescription, and parasite-control recommendations.
The home care segment is expected to witness the fastest CAGR of 7.22% from 2026 to 2033, supported by increasing preference for convenient at-home preventive care, greater awareness of routine parasite prevention, and the growing availability of easy-to-administer animal health products.
-
By Distribution Channel
On the basis of distribution channel, the market is segmented into retail sales, direct tender, and other. In 2026, retail sales are expected to dominate with a market share of 67.44%, supported by broad access to companion-animal parasite-control products through retail and pet-care channels.
The direct tender segment is expected to witness the fastest CAGR of 7.16% from 2026 to 2033, supported by increasing institutional and farm-level procurement, rising demand for bulk purchasing, and the growing adoption of organized procurement channels for animal health products.
Germany Animal Parasiticides Market Insight
Germany dominated the Europe animal parasiticides market with the largest revenue share of 21.66% in 2025, supported by supported by its well-established veterinary healthcare infrastructure, high demand for companion-animal healthcare, strong adoption of preventive parasite-control products, and the presence of leading animal health companies and veterinary pharmaceutical manufacturers.
U.K. Animal Parasiticides Market Insight
The U.K. animal parasiticides market is driven by increasing pet ownership, strong awareness of preventive animal healthcare, rising livestock health-management practices, and the need to control parasites such as fleas, ticks, mites, gastrointestinal worms, and other internal and external parasites. Growth is further supported by the availability of prescription and over-the-counter products through veterinary clinics, pharmacies, agricultural suppliers, and online channels.
Italy Animal Parasiticides Market Insight
The Italy animal parasiticides market is supported by rising companion-animal ownership, increasing emphasis on preventive veterinary care, and continued demand for parasite control across livestock and farm animals. Market growth is further encouraged by awareness of flea, tick, mite, and gastrointestinal parasite prevention, along with established veterinary healthcare infrastructure and access to animal medicines.
Spain Animal Parasiticides Market Insight
The Spain animal parasiticides market is supported by increasing adoption of preventive veterinary care, growing companion-animal ownership, and the need for effective parasite control across livestock and farm animals. Market growth is further driven by rising awareness of flea, tick, mite, and gastrointestinal parasite prevention, alongside established veterinary healthcare infrastructure and access to animal health products.
Russia Animal Parasiticides Market Insight
The Russia animal parasiticides market is supported by the large livestock population, increasing focus on animal health and productivity, and continued demand for parasite control in cattle, pigs, sheep, poultry, and companion animals. Market growth is further driven by the need to prevent parasitic infections, improve livestock productivity, and maintain routine veterinary health programs.
Europe Animal Parasiticides Market Share
The animal parasiticides industry is primarily led by well-established companies, including:
- Zoetis Inc. (U.S.)
- Boehringer Ingelheim International GmbH (Germany)
- Bimeda, Inc. (Ireland)
- Biogénesis Bagó (Argentina)
- Ceva Santé Animale (France)
- Dechra Pharmaceuticals (U.K.)
- Elanco Animal Health Incorporated (U.S.)
- Merck & Co., Inc. (U.S.)
- Vetoquinol (France)
- Virbac (France)
- Norbrook (U.K.)
- FARMABASE (Spain)
- Ourofino Saúde Animal (Brazil)
- Phibro Animal Health Corporation (U.S.)
- PetIQ, LLC (U.S.)
- Chanelle Pharma (Ireland)
- Inmed Animal Health (U.S.)
- Viyash Scientific (India)
- Kyoritsu Seiyaku Corporation (Japan)
- KRKA, d. d., Novo mesto (Slovenia)
- Huvepharma (Bulgaria)
- Bioveta, a.s. (Czech Republic)
- Pecus Healthcare Pvt. Ltd. (India)
- PATCO Healthcare Pvt. Ltd. (India)
- Agrovet Market S.A. (Peru)
- Prodivet Pharmaceuticals S.A. (Belgium)
Latest Developments in Europe Animal Parasiticides Market
- In September 2025, Zoetis Inc. announced that Dectomax-CA1 Injectable is the first and only parasite control product to receive conditional approval from the U.S. Food and Drug Administration for the prevention and treatment of infestations caused by the larvae of Cochliomyia hominivorax (myiasis), and prevention of reinfestation for 21 days. This conditional approval applies to beef cattle, female dairy cattle less than 20 months of age, pregnant beef cows, newborn calves and bulls.
- In February 2026, Boehringer Ingelheim, a global leader in animal health, announced that the U.S. Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for the use of IVOMEC (ivermectin) 1% Injection for the prevention of infestations caused by New World screwworm (NWS) in cattle. Under the EUA, IVOMEC (ivermectin) 1% Injection is authorized for the prevention of infestations caused by NWS (Cochliomyia hominivorax) larvae (myiasis) when administered within 24 hours of birth, at the time of castration, or at the appearance of a wound in cattle, except for female dairy cattle producing milk for human consumption and calves that will be processed for veal.
- In June 2026, Ceva Animal Health announces the acquisition of Aquilón CyL S.L., a Spanish biotechnology company specialised in research, diagnostics, and the development of innovative biological solutions for swine diseases. This acquisition enhances Ceva’s swine intestinal health portfolio. It includes the first and only European commercial vaccine targeting Brachyspira hyodysenteriae, the bacterium responsible for swine dysentery, a major enteric disease causing severe economic losses globally.
- In May 2026, Ceva Animal Health (Ceva) and Mitsui & Co., Ltd. (Mitsui) announced the creation of Ceva Bussan Animal Health, a new joint venture that brings together Bussan Animal Health (BAH) and Ceva Japan. As part of the transaction, Mitsui has transferred 60% of its shareholding in BAH to Ceva. Ceva Bussan Animal Health will be operated by Ceva as a controlling shareholder and benefit from Mitsui’s ongoing support as a leading global trading and investment company headquartered in Japan.
- In February 2026, Ceva Animal Health is implementing strategic organisational changes across Asia Pacific (APAC) and China to accelerate growth and drive operational excellence. As part of this strategic realignment, Ceva has relocated its Asia-Pacific regional headquarters to Shanghai, positioning the company to serve the dynamic markets in the region more effectively.
- Interactive Data Analysis Dashboard
- Company Analysis Dashboard for high growth potential opportunities
- Research Analyst Access for customization & queries
- Competitor Analysis with Interactive dashboard
- Latest News, Updates & Trend analysis
- Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF EUROPE ANIMAL PARASITICIDES MARKET
1.4 CURRENCY AND PRICING
1.5 LIMITATIONS
1.6 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 DBMR TRIPOD DATA VALIDATION MODEL
2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.6 DBMR MARKET POSITION GRID
2.7 VENDOR SHARE ANALYSIS
2.8 MULTIVARIATE MODELING
2.9 PRODUCT TYPE TIMELINE CURVE
2.1 MARKET APPLICATION COVERAGE GRID
2.11 SECONDARY SOURCES
2.12 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PORTER’S FIVE FORCES ANALYSIS
4.1.1 THREAT OF NEW ENTRANTS
4.1.2 BARGAINING POWER OF SUPPLIERS
4.1.3 BARGAINING POWER OF BUYERS
4.1.4 THREAT OF SUBSTITUTE PRODUCTS
4.1.5 INDUSTRY RIVALRY
4.2 PESTEL ANALYSIS
4.2.1 INTRODUCTION
4.2.2 POLITICAL FACTORS
4.2.2.1 ANIMAL DISEASE CONTROL POLICIES
4.2.2.2 GOVERNMENT LIVESTOCK HEALTH PROGRAMS
4.2.2.3 ZOONOTIC DISEASE PREVENTION INITIATIVES
4.2.3 ECONOMIC FACTORS
4.2.4 RISING VETERINARY HEALTHCARE COSTS
4.2.4.1 LIVESTOCK PRODUCTIVITY INVESTMENTS
4.2.4.2 DEMAND FOR AFFORDABLE TREATMENTS
4.2.4.3 EXPANSION OF ANIMAL HEALTHCARE SPENDING
4.2.4.4 GENERIC PARASITICIDE ADOPTION
4.2.5 SOCIAL FACTORS
4.2.5.1 GROWING ANIMAL HEALTH AWARENESS
4.2.5.2 PREVENTIVE PARASITE MANAGEMENT PRACTICES
4.2.5.3 RISING PET OWNERSHIP TRENDS
4.2.5.4 ANIMAL WELFARE CONCERNS
4.2.5.5 DEMAND FOR BETTER VETERINARY CARE
4.2.6 TECHNOLOGICAL FACTORS
4.2.6.1 ADVANCED PARASITICIDE FORMULATIONS
4.2.6.2 NOVEL DRUG DELIVERY SYSTEMS
4.2.6.3 DIGITAL VETERINARY PLATFORMS
4.2.6.4 IMPROVED PARASITE DIAGNOSTICS
4.2.6.5 RESEARCH ON NEW MOLECULES
4.2.7 ENVIRONMENTAL FACTORS
4.2.7.1 PARASITICIDE RESIDUE CONCERNS
4.2.7.2 VETERINARY WASTE MANAGEMENT
4.2.7.3 SUSTAINABLE MANUFACTURING PRACTICES
4.2.7.4 ECO-FRIENDLY PACKAGING ADOPTION
4.2.7.5 RESISTANCE MANAGEMENT INITIATIVES
4.2.8 LEGAL FACTORS
4.2.8.1 VETERINARY DRUG APPROVAL STANDARDS
4.2.8.2 SAFETY AND EFFICACY REGULATIONS
4.2.8.3 RESIDUE LIMIT COMPLIANCE
4.2.8.4 ANIMAL MEDICINE GUIDELINES
4.2.8.5 EUROPE REGULATORY HARMONIZATION
4.2.9 CONCLUSION
4.3 PATENT ANALYSIS
4.3.1 PATENT NUMBER AND EXPIRY
4.3.2 COUNTRY-LEVEL APPROVAL
4.3.3 LIST OF PRODUCTS REACHING EXPIRY IN NEXT 3 YEARS
4.3.4 PRODUCTS PATENTED IN SPECIFIC COUNTRIES
4.3.5 CONCLUSION
4.4 INDUSTRY INSIGHTS
4.5 PIPELINE ANALYSIS
4.5.1 CLINICAL TRIALS AND PHASE ANALYSIS
4.5.2 PRODUCT PIPELINE FOR ANIMAL PARASITICIDES
4.5.3 TARGET ANIMAL SAFETY STUDIES (TASS)
4.5.4 TARGET ANIMAL EFFECTIVENESS STUDIES (TAES)
4.6 R & D ANALYSIS
4.7 EPIDEMIOLOGY
4.7.1 INTRODUCTION
4.7.2 INCIDENCE OF INFESTATION BY REGION
4.7.3 TREATMENT ADOPTION RATE
4.7.4 PARASITE-RELATED MORTALITY RATE
4.7.5 COMPLIANCE AND THERAPY SWITCH MODEL
4.7.6 TREATMENT SUCCESS RATES
4.7.7 CONCLUSION
4.8 MARKETED PRODUCT ANALYSIS
4.8.1 INTRODUCTION
4.8.2 PRODUCT
4.8.2.1 BRAND NAME
4.8.2.2 GENERIC NAME
4.8.3 THERAPEUTIC INDICATION
4.8.4 PHARMACOLOGICAL CLASSIFICATION
4.8.5 PRIMARY INDICATION
4.8.6 MARKET STATUS
4.8.7 MEDICATION TYPE
4.8.8 PRODUCT DOSAGE FORM
4.8.9 DOSAGE AVAILABILITY
4.8.10 PACKAGING TYPE
4.8.11 ROUTE OF ADMINISTRATION
4.8.12 DOSING FREQUENCY
4.8.13 PRODUCT INSIGHT
4.8.14 OVERVIEW OF PRODUCT DEVELOPMENT (REGULATORY MILESTONES, SAFETY, EFFICACY, MARKET EXCLUSIVITY DATA)
4.8.14.1 FORECAST MARKET OUTLOOK
4.8.14.2 CROSS COMPETITION
4.8.14.3 PRODUCT PORTFOLIO
4.8.14.4 URRENT DEVELOPMENT SCENARIO
4.8.15 CONCLUSION
4.9 MARKET ACCESS
4.9.1 INTRODUCTION
4.9.2 10-YEAR MARKET FORECAST
4.9.3 CLINICAL TRIAL RECENT UPDATES
4.9.4 ANNUAL NEW APPROVED PRODUCTS
4.9.5 MAJOR MANUFACTURERS AND PARTNERSHIPS
4.9.6 MAJOR PRODUCT UPTAKE
4.9.7 CURRENT TREATMENT PRACTICES
4.9.8 IMPACT OF UPCOMING THERAPY TRENDS
4.9.9 CONCLUSION
5 HEALTHCARE TARIFFS IMPACT ANALYSIS
5.1 OVERVIEW
5.2 TARIFF STRUCTURES
5.2.1 EUROPE VS. REGIONAL TARIFF STRUCTURES
5.2.1.1 NORTH AMERICA
5.2.1.2 EUROPE
5.2.1.3 ASIA-PACIFIC
5.2.1.4 LATIN AMERICA
5.2.1.5 MIDDLE EAST AND AFRICA
5.2.2 UNITED STATES: USDA AND FDA TARIFF POLICIES, CMS PRICING MODELS
5.2.3 EUROPEAN UNION: CROSS-BORDER TARIFF REGULATIONS, REIMBURSEMENT POLICIES
5.2.4 ASIA-PACIFIC: GOVERNMENT-IMPOSED TARIFFS ON IMPORTED VETERINARY PRODUCTS
5.2.5 EMERGING MARKETS: CHALLENGES IN TARIFF IMPLEMENTATION
5.3 PHARMACEUTICAL TARIFFS AND TRADE BARRIERS
5.3.1 IMPORT DUTIES ON VETERINARY DRUGS VS. GENERICS
5.3.2 IMPACT ON PRODUCT AFFORDABILITY AND ACCESS
5.3.3 KEY TRADE AGREEMENTS AFFECTING TARIFFS
5.4 IMPACT OF HEALTHCARE TARIFFS ON PROVIDERS AND ANIMAL OWNERS
5.4.1 COST BURDEN ON FARMS, HOSPITALS, AND VETERINARY CLINICS
5.4.2 EFFECT ON PET OWNER AFFORDABILITY AND INSURANCE COVERAGE
5.4.3 TARIFFS AND THEIR ROLE IN VETERINARY TOURISM
5.5 TRADE AGREEMENTS AND HEALTHCARE TARIFFS
5.5.1 WTO REGULATIONS ON HEALTHCARE TARIFFS
5.5.2 IMPACT OF TRADE WARS ON SUPPLY CHAIN
5.5.3 WTO ROLE OF FREE TRADE AGREEMENTS IN REDUCING TARIFFS
5.6 IMPACT OF TARIFFS ON COSTS AND ACCESSIBILITY
5.7 IMPORTANCE OF TARIFFS IN THE SECTOR
6 REGULATORY FRAMEWORK
6.1 INTRODUCTION
6.2 REGULATORY APPROVAL PROCESS
6.3 GEOGRAPHIES’ EASE OF REGULATORY APPROVAL
6.4 REGULATORY APPROVAL PATHWAYS
6.5 LICENSING AND REGISTRATION
6.6 POST-MARKETING SURVEILLANCE
6.7 GOOD MANUFACTURING PRACTICES (GMPS) GUIDELINES
6.8 CONCLUSION
7 MARKET OVERVIEW
7.1 DRIVERS
7.1.1 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH.
7.1.2 RISING PET HUMANIZATION AND GROWING EXPENDITURE ON COMPANION ANIMAL WELLNESS.
7.1.3 INCREASING IMPORTANCE OF LIVESTOCK DISEASE MANAGEMENT FOR FOOD SUPPLY CHAIN STABILITY
7.1.4 INCREASING VETERINARY RECOMMENDATIONS FOR PREVENTIVE PARASITE CONTROL PRACTICES
7.2 RESTRAINTS
7.2.1 DEVELOPMENT OF PARASITE RESISTANCE AGAINST COMMONLY USED ACTIVE INGREDIENTS.
7.2.2 STRICT REGULATORY APPROVAL REQUIREMENTS FOR VETERINARY PHARMACEUTICAL PRODUCTS
7.3 OPPORTUNITIES
7.3.1 GROWTH IN DEMAND FOR NOVEL BIOLOGICAL AND LOW-CHEMICAL RESIDUE PARASITICIDE SOLUTIONS
7.3.2 EXPANSION OF ONLINE VETERINARY SERVICES AND DIGITAL ANIMAL HEALTHCARE PLATFORMS
7.3.3 DEVELOPMENT OF CUSTOMIZED PARASITE CONTROL SOLUTIONS BASED ON ANIMAL TYPE AND GEOGRAPHIC RISK
7.4 CHALLENGES
7.4.1 LIMITED VETERINARY INFRASTRUCTURE IN RURAL AND REMOTE FARMING COMMUNITIES
7.4.2 ENVIRONMENTAL IMPACT CONCERNS RELATED TO PARASITICIDE RESIDUES
8 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT
8.1 OVERVIEW
8.2 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
8.2.1 ECTOPARASITICIDES
8.2.2 ENDOPARASITICIDES
8.2.3 ENDECTOCIDES
8.3 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
8.3.1 ECTOPARASITICIDES
8.3.2 ENDOPARASITICIDES
8.3.3 ENDECTOCIDES
8.4 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
8.4.1 ECTOPARASITICIDES
8.4.2 ENDOPARASITICIDES
8.4.3 ENDECTOCIDES
8.5 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
8.5.1 BY TYPE
8.5.2 BY DOSAGE FORM
8.5.3 BY ROUTE OF ADMINISTRATION
8.6 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.6.1 ORGANOPHOSPHATES
8.6.2 CARBAMATES
8.6.3 ORGANOCHLORINES
8.6.4 OTHERS
8.7 EUROPE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.7.1 LINDANE
8.7.2 DIELDRIN
8.7.3 OTHERS
8.8 EUROPE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.8.1 CARBARYL
8.8.2 METHOMYL
8.8.3 OTHERS
8.9 EUROPE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.9.1 CHLORPYRIFOS
8.9.2 AZAMETHIPHOS
8.9.3 CHLORFENVINPHOS
8.9.4 OTHERS
8.1 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
8.10.1 SOLUTION
8.10.2 TABLETS
8.10.3 SPRAYS
8.10.4 OTHERS
8.11 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
8.11.1 TOPICAL
8.11.2 ORAL
8.11.3 OTHERS
8.12 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.12.1 NORTH AMERICA
8.12.2 EUROPE
8.12.3 ASIA-PACIFIC
8.12.4 SOUTH AMERICA
8.12.5 MIDDLE EAST & AFRICA
8.13 EUROPE ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
8.13.1 BY TYPE
8.13.2 BY DOSAGE FORM
8.13.3 BY ROUTE OF ADMINISTRATION
8.14 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.14.1 BENZIMIDAZOLES
8.14.2 IMIDAZOTHIAZOLES
8.14.3 OTHERS
8.15 EUROPE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.15.1 ALBENDAZOLE
8.15.2 FENBENDAZOLE
8.15.3 FEBANTEL
8.15.4 OTHERS
8.16 EUROPE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.16.1 LEVAMISOLE
8.16.2 TETRAMISOLE
8.16.3 OTHERS
8.17 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
8.17.1 SOLUTION
8.17.2 TABLETS
8.17.3 SPRAYS
8.17.4 OTHERS
8.18 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
8.18.1 ORAL
8.18.2 INJECTABLES
8.18.3 TOPICAL
8.18.4 OTHERS
8.19 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.19.1 NORTH AMERICA
8.19.2 EUROPE
8.19.3 ASIA-PACIFIC
8.19.4 SOUTH AMERICA
8.19.5 MIDDLE EAST & AFRICA
8.2 EUROPE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
8.20.1 ABAMECTIN
8.20.2 DORAMECTIN
8.20.3 OTHERS
8.21 EUROPE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
8.21.1 NORTH AMERICA
8.21.2 EUROPE
8.21.3 ASIA-PACIFIC
8.21.4 SOUTH AMERICA
8.21.5 MIDDLE EAST & AFRICA
9 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG CLASS
9.1 OVERVIEW
9.2 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
9.2.1 ORGANOCHLORINES
9.2.2 ORGANOPHOSPHATES
9.2.3 CARBAMATES
9.2.4 BENZIMIDAZOLES
9.2.5 IMIDAZOTHIAZOLES
9.2.6 OTHERS
9.3 EUROPE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.3.1 NORTH AMERICA
9.3.2 EUROPE
9.3.3 ASIA-PACIFIC
9.3.4 SOUTH AMERICA
9.3.5 MIDDLE EAST & AFRICA
9.4 EUROPE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.4.1 NORTH AMERICA
9.4.2 EUROPE
9.4.3 ASIA-PACIFIC
9.4.4 SOUTH AMERICA
9.4.5 MIDDLE EAST & AFRICA
9.5 EUROPE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.5.1 NORTH AMERICA
9.5.2 EUROPE
9.5.3 ASIA-PACIFIC
9.5.4 SOUTH AMERICA
9.5.5 MIDDLE EAST & AFRICA
9.6 EUROPE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.6.1 NORTH AMERICA
9.6.2 EUROPE
9.6.3 ASIA-PACIFIC
9.6.4 SOUTH AMERICA
9.6.5 MIDDLE EAST & AFRICA
9.7 EUROPE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.7.1 NORTH AMERICA
9.7.2 EUROPE
9.7.3 ASIA-PACIFIC
9.7.4 SOUTH AMERICA
9.7.5 MIDDLE EAST & AFRICA
9.8 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
9.8.1 NORTH AMERICA
9.8.2 EUROPE
9.8.3 ASIA-PACIFIC
9.8.4 SOUTH AMERICA
9.8.5 MIDDLE EAST & AFRICA
10 EUROPE ANIMAL PARASITICIDES MARKET , BY MODE OF PURCHASE
10.1 OVERVIEW
10.2 EUROPE ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
10.2.1 PRESCRIPTION
10.2.2 OVER THE COUNTER (OTC)
10.3 EUROPE PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.3.1 NORTH AMERICA
10.3.2 EUROPE
10.3.3 ASIA-PACIFIC
10.3.4 SOUTH AMERICA
10.3.5 MIDDLE EAST & AFRICA
10.4 EUROPE OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
10.4.1 NORTH AMERICA
10.4.2 EUROPE
10.4.3 ASIA-PACIFIC
10.4.4 SOUTH AMERICA
10.4.5 MIDDLE EAST & AFRICA
11 EUROPE ANIMAL PARASITICIDES MARKET , BY DRUG TYPE
11.1 OVERVIEW
11.2 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
11.2.1 BRANDED
11.2.2 GENERIC
11.3 EUROPE BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.3.1 NORTH AMERICA
11.3.2 EUROPE
11.3.3 ASIA-PACIFIC
11.3.4 SOUTH AMERICA
11.3.5 MIDDLE EAST & AFRICA
11.4 EUROPE GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
11.4.1 NORTH AMERICA
11.4.2 EUROPE
11.4.3 ASIA-PACIFIC
11.4.4 SOUTH AMERICA
11.4.5 MIDDLE EAST & AFRICA
12 EUROPE ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION
12.1 OVERVIEW
12.2 EUROPE ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
12.2.1 TOPICAL
12.2.2 ORAL
12.2.3 INJECTABLES
12.2.4 OTHERS
12.3 EUROPE TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.3.1 NORTH AMERICA
12.3.2 EUROPE
12.3.3 ASIA-PACIFIC
12.3.4 SOUTH AMERICA
12.3.5 MIDDLE EAST & AFRICA
12.4 EUROPE ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.4.1 NORTH AMERICA
12.4.2 EUROPE
12.4.3 ASIA-PACIFIC
12.4.4 SOUTH AMERICA
12.4.5 MIDDLE EAST & AFRICA
12.5 EUROPE INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.5.1 NORTH AMERICA
12.5.2 EUROPE
12.5.3 ASIA-PACIFIC
12.5.4 SOUTH AMERICA
12.5.5 MIDDLE EAST & AFRICA
12.6 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
12.6.1 NORTH AMERICA
12.6.2 EUROPE
12.6.3 ASIA-PACIFIC
12.6.4 SOUTH AMERICA
12.6.5 MIDDLE EAST & AFRICA
13 EUROPE ANIMAL PARASITICIDES MARKET , BY DOSAGE FORM
13.1 OVERVIEW
13.2 EUROPE ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
13.2.1 SOLUTION
13.2.2 TABLETS
13.2.3 SPRAYS
13.2.4 OTHERS
13.3 EUROPE SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.3.1 NORTH AMERICA
13.3.2 EUROPE
13.3.3 ASIA-PACIFIC
13.3.4 SOUTH AMERICA
13.3.5 MIDDLE EAST & AFRICA
13.4 EUROPE TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.4.1 NORTH AMERICA
13.4.2 EUROPE
13.4.3 ASIA-PACIFIC
13.4.4 SOUTH AMERICA
13.4.5 MIDDLE EAST & AFRICA
13.5 EUROPE SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.5.1 NORTH AMERICA
13.5.2 EUROPE
13.5.3 ASIA-PACIFIC
13.5.4 SOUTH AMERICA
13.5.5 MIDDLE EAST & AFRICA
13.6 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
13.6.1 NORTH AMERICA
13.6.2 EUROPE
13.6.3 ASIA-PACIFIC
13.6.4 SOUTH AMERICA
13.6.5 MIDDLE EAST & AFRICA
14 EUROPE ANIMAL PARASITICIDES MARKET , BY DISEASE TYPE
14.1 OVERVIEW
14.2 EUROPE ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE, 2018-2033 (USD THOUSAND)
14.2.1 FLEAS
14.2.2 TICKS
14.2.3 ROUND WORMS
14.2.4 HOOKWORMS
14.2.5 EAR MITES
14.2.6 OTHERS
14.3 EUROPE FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.3.1 NORTH AMERICA
14.3.2 EUROPE
14.3.3 ASIA-PACIFIC
14.3.4 SOUTH AMERICA
14.3.5 MIDDLE EAST & AFRICA
14.4 EUROPE TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.4.1 NORTH AMERICA
14.4.2 EUROPE
14.4.3 ASIA-PACIFIC
14.4.4 SOUTH AMERICA
14.4.5 MIDDLE EAST & AFRICA
14.5 EUROPE ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.5.1 NORTH AMERICA
14.5.2 EUROPE
14.5.3 ASIA-PACIFIC
14.5.4 SOUTH AMERICA
14.5.5 MIDDLE EAST & AFRICA
14.6 EUROPE HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.6.1 NORTH AMERICA
14.6.2 EUROPE
14.6.3 ASIA-PACIFIC
14.6.4 SOUTH AMERICA
14.6.5 MIDDLE EAST & AFRICA
14.7 EUROPE EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.7.1 NORTH AMERICA
14.7.2 EUROPE
14.7.3 ASIA-PACIFIC
14.7.4 SOUTH AMERICA
14.7.5 MIDDLE EAST & AFRICA
14.8 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
14.8.1 NORTH AMERICA
14.8.2 EUROPE
14.8.3 ASIA-PACIFIC
14.8.4 SOUTH AMERICA
14.8.5 MIDDLE EAST & AFRICA
15 EUROPE ANIMAL PARASITICIDES MARKET , BY ANIMAL TYPE
15.1 OVERVIEW
15.2 EUROPE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
15.2.1 COMPANION ANIMAL
15.2.2 FARM ANIMALS
15.3 EUROPE ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
15.3.1 DOGS
15.3.2 CATS
15.3.3 HORSES
15.3.4 OTHER COMPANION ANIMALS
15.4 EUROPE COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.4.1 NORTH AMERICA
15.4.2 EUROPE
15.4.3 ASIA-PACIFIC
15.4.4 SOUTH AMERICA
15.4.5 MIDDLE EAST & AFRICA
15.5 EUROPE ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
15.5.1 CATTLE
15.5.2 SWINE
15.5.3 SHEEP AND GOATS
15.5.4 POULTRY
15.5.5 OTHER FARM ANIMALS
15.6 EUROPE FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
15.6.1 NORTH AMERICA
15.6.2 EUROPE
15.6.3 ASIA-PACIFIC
15.6.4 SOUTH AMERICA
15.6.5 MIDDLE EAST & AFRICA
16 EUROPE ANIMAL PARASITICIDES MARKET , BY END USER
16.1 OVERVIEW
16.2 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
16.2.1 VETERINARY CLINICS
16.2.2 ANIMAL FARMS
16.2.3 HOME CARE
16.2.4 VETERINARY HOSPITALS
16.2.5 PET SHOPS
16.2.6 OTHERS
16.3 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
16.3.1 VETERINARY CLINICS
16.3.2 ANIMAL FARMS
16.3.3 HOME CARE
16.3.4 VETERINARY HOSPITALS
16.3.5 PET SHOPS
16.3.6 OTHERS
16.4 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
16.4.1 VETERINARY CLINICS
16.4.2 ANIMAL FARMS
16.4.3 HOME CARE
16.4.4 VETERINARY HOSPITALS
16.4.5 PET SHOPS
16.4.6 OTHERS
16.5 EUROPE VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.5.1 NORTH AMERICA
16.5.2 EUROPE
16.5.3 ASIA-PACIFIC
16.5.4 SOUTH AMERICA
16.5.5 MIDDLE EAST & AFRICA
16.6 EUROPE ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.6.1 NORTH AMERICA
16.6.2 EUROPE
16.6.3 ASIA-PACIFIC
16.6.4 SOUTH AMERICA
16.6.5 MIDDLE EAST & AFRICA
16.7 EUROPE HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.7.1 NORTH AMERICA
16.7.2 EUROPE
16.7.3 ASIA-PACIFIC
16.7.4 SOUTH AMERICA
16.7.5 MIDDLE EAST & AFRICA
16.8 EUROPE ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
16.8.1 PRIVATE
16.8.2 PUBLIC
16.9 EUROPE VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.9.1 NORTH AMERICA
16.9.2 EUROPE
16.9.3 ASIA-PACIFIC
16.9.4 SOUTH AMERICA
16.9.5 MIDDLE EAST & AFRICA
16.1 EUROPE PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.10.1 NORTH AMERICA
16.10.2 EUROPE
16.10.3 ASIA-PACIFIC
16.10.4 SOUTH AMERICA
16.10.5 MIDDLE EAST & AFRICA
16.11 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
16.11.1 NORTH AMERICA
16.11.2 EUROPE
16.11.3 ASIA-PACIFIC
16.11.4 SOUTH AMERICA
16.11.5 MIDDLE EAST & AFRICA
17 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL
17.1 OVERVIEW
17.2 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
17.2.1 RETAIL SALES
17.2.2 DIRECT TENDER
17.2.3 OTHER
17.3 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
17.3.1 RETAIL SALES
17.3.2 DIRECT TENDER
17.3.3 OTHER
17.4 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
17.4.1 RETAIL SALES
17.4.2 DIRECT TENDER
17.4.3 OTHER
17.5 EUROPE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
17.5.1 OFFLINE SALES
17.5.2 ONLINE SALES
17.6 EUROPE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.6.1 NORTH AMERICA
17.6.2 EUROPE
17.6.3 ASIA-PACIFIC
17.6.4 SOUTH AMERICA
17.6.5 MIDDLE EAST & AFRICA
17.7 EUROPE DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.7.1 NORTH AMERICA
17.7.2 EUROPE
17.7.3 ASIA-PACIFIC
17.7.4 SOUTH AMERICA
17.7.5 MIDDLE EAST & AFRICA
17.8 EUROPE OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
17.8.1 NORTH AMERICA
17.8.2 EUROPE
17.8.3 ASIA-PACIFIC
17.8.4 SOUTH AMERICA
17.8.5 MIDDLE EAST & AFRICA
18 EUROPE ANIMAL PARASITICIDES MARKET, BY REGION
18.1 EUROPE
18.1.1 GERMANY
18.1.2 U.K.
18.1.3 FRANCE
18.1.4 ITALY
18.1.5 SPAIN
18.1.6 RUSSIA
18.1.7 SWITZERLAND
18.1.8 NETHERLAND
18.1.9 TURKEY
18.1.10 BELGIUM
18.1.11 DENMARK
18.1.12 SWEDEN
18.1.13 NORWAY
18.1.14 FINLAND
18.1.15 REST OF EUROPE
19 EUROPE ANIMAL PARASITICIDES MARKET COMPANY LANDSCAPE
19.1 COMPANY SHARE ANALYSIS: GLOBAL
20 SWOT ANALYSIS
21 COMPANY PROFILES
21.1 ZOETIS SERVICES LLC
21.1.1 COMPANY SNAPSHOT
21.1.2 REVENUE ANALYSIS
21.1.3 COMPANY SHARE ANALYSIS
21.1.4 PRODUCT PORTFOLIO
21.1.5 RECENT DEVELOPMENT
21.2 MERCK & CO., INC
21.2.1 COMPANY SNAPSHOT
21.2.2 REVENUE ANALYSIS
21.2.3 COMPANY SHARE ANALYSIS
21.2.4 PRODUCT PORTFOLIO
21.2.5 RECENT DEVELOPMENT
21.3 BOEHRINGER INGELHEIM INTERNATIONAL GMBH
21.3.1 COMPANY SNAPSHOT
21.3.2 COMPANY SHARE ANALYSIS
21.3.3 PRODUCT PORTFOLIO
21.3.4 RECENT DEVELOPMENT
21.4 ELANCO
21.4.1 COMPANY SNAPSHOT
21.4.2 REVENUE ANALYSIS
21.4.3 COMPANY SHARE ANALYSIS
21.4.4 PRODUCT PORTFOLIO
21.4.5 RECENT DEVELOPMENT
21.5 CEVA
21.5.1 COMPANY SNAPSHOT
21.5.2 COMPANY SHARE ANALYSIS
21.5.3 PRODUCT PORTFOLIO
21.5.4 RECENT DEVELOPMENT
21.6 AGROVET MARKET ANIMAL HEALTH
21.6.1 COMPANY SNAPSHOT
21.6.2 PRODUCT PORTFOLIO
21.6.3 RECENT DEVELOPMENT
21.7 BIMEDA, INC.
21.7.1 COMPANY SNAPSHOT
21.7.2 PRODUCT PORTFOLIO
21.7.3 RECENT DEVELOPMENT
21.8 BIOGÉNESIS BAGÓ
21.8.1 COMPANY SNAPSHOT
21.8.2 PRODUCT PORTFOLIO
21.8.3 RECENT DEVELOPMENT
21.9 BIOVETA, A.S
21.9.1 COMPANY SNAPSHOT
21.9.2 PRODUCT PORTFOLIO
21.9.3 RECENT DEVELOPMENT
21.1 CHANELLE PHARMA
21.10.1 COMPANY SNAPSHOT
21.10.2 PRODUCT PORTFOLIO
21.10.3 RECENT DEVELOPMENT/NEWS
21.11 DECHRA PHARMACEUTICALS
21.11.1 COMPANY SNAPSHOT
21.11.2 PRODUCT PORTFOLIO
21.11.3 RECENT DEVELOPMENT
21.12 FARMABASE
21.12.1 COMPANY SNAPSHOT
21.12.2 PRODUCT PORTFOLIO
21.12.3 RECENT DEVELOPMENT
21.13 HUVEPHARMA
21.13.1 COMPANY SNAPSHOT
21.13.2 PRODUCT PORTFOLIO
21.13.3 RECENT DEVELOPMENT
21.14 INMED ANIMAL HEALTH
21.14.1 COMPANY SNAPSHOT
21.14.2 PRODUCT PORTFOLIO
21.14.3 RECENT DEVELOPMENT/NEWS
21.15 KRKA, D. D., NOVO MESTO
21.15.1 COMPANY SNAPSHOT
21.15.2 REVENUE ANALYSIS
21.15.3 PRODUCT PORTFOLIO
21.15.4 RECENT DEVELOPMENT
21.16 KYORITSU SEIYAKU CORPORATION
21.16.1 COMPANY SNAPSHOT
21.16.2 PRODUCT PORTFOLIO
21.16.3 RECENT DEVELOPMENT
21.17 NORBROOK
21.17.1 COMPANY SNAPSHOT
21.17.2 PRODUCT PORTFOLIO
21.17.3 RECENT DEVELOPMENT
21.18 OUROFINO SAÚDE ANIMAL
21.18.1 COMPANY SNAPSHOT
21.18.2 REVENUE ANALYSIS
21.18.3 PRODUCT PORTFOLIO
21.18.4 RECENT DEVELOPMENT
21.19 ATCO HEALTHCARE PVT. LTD.
21.19.1 COMPANY SNAPSHOT
21.19.2 PRODUCT PORTFOLIO
21.19.3 RECENT DEVELOPMENT
21.2 PECUS HEALTHCARE PVT LTD
21.20.1 COMPANY SNAPSHOT
21.20.2 PRODUCT PORTFOLIO
21.20.3 RECENT DEVELOPMENT
21.21 PETIQ, LLC
21.21.1 COMPANY SNAPSHOT
21.21.2 PRODUCT PORTFOLIO
21.21.3 RECENT DEVELOPMENT
21.22 PHIBRO
21.22.1 COMPANY SNAPSHOT
21.22.2 PRODUCT PORTFOLIO
21.22.3 RECENT DEVELOPMENT/NEWS
21.23 PRODIVET PHARMACEUTICALS
21.23.1 COMPANY SNAPSHOT
21.23.2 PRODUCT PORTFOLIO
21.23.3 RECENT DEVELOPMENT
21.24 VETOQUINOL
21.24.1 COMPANY SNAPSHOT
21.24.2 REVENUE ANALYSIS
21.24.3 PRODUCT PORTFOLIO
21.24.4 RECENT DEVELOPMENT
21.25 VIRBAC.
21.25.1 COMPANY SNAPSHOT
21.25.2 REVENUE ANALYSIS
21.25.3 PRODUCT PORTFOLIO
21.25.4 RECENT DEVELOPMENT
21.26 VIYASH SCIENTIFIC LTD.
21.26.1 COMPANY SNAPSHOT
21.26.2 PRODUCT PORTFOLIO
21.26.3 RECENT DEVELOPMENT/NEWS
21.26.4 PRODUCT PORTFOLIO
21.26.5 RECENT DEVELOPMENT
22 QUESTIONNAIRE
23 RELATED REPORTS
List of Table
TABLE 1 PESTEL ANALYSIS OVERVIEW
TABLE 2 GROWTH OPPORTUNITY MAPPING
TABLE 3 CLINICAL TRIAL MARKET FOR EUROPE ANIMAL PARASITICIDES MARKET
TABLE 4 DISTRIBUTION OF PROJECTS BY PARASITE TYPE AND PHASE EUROPE ANIMAL
TABLE 5 DISTRIBUTION OF PROJECTS BY SCIENTIFIC APPROACH AND PHASE EUROPE ANIMAL PARASITICIDES MARKET
TABLE 6 COMPARATIVE EVOLUTION OF R&D STRATEGIES
TABLE 7 ANIMAL PARASITICIDE PRODUCT DEVELOPMENT LIFECYCLE
TABLE 8 REGULATORY MILESTONES ACROSS THE PRODUCT DEVELOPMENT LIFECYCLE
TABLE 9 EMERGING THERAPEUTIC INNOVATION ASSESSMENT
TABLE 10 MAJOR COLLABORATION MODELS IN ANIMAL PARASITICIDE R&D
TABLE 11 TEN-YEAR MARKET FORECAST, 2023–2033 (USD MILLION)
TABLE 12 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 13 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 14 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 15 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 16 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 17 EUROPE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 18 EUROPE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 19 EUROPE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 20 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 21 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 22 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 23 EUROPE ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 24 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 25 EUROPE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 26 EUROPE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 27 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 28 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 29 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 30 EUROPE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 31 EUROPE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 32 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 33 EUROPE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 34 EUROPE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 35 EUROPE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 36 EUROPE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 37 EUROPE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 38 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 39 EUROPE ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 40 EUROPE PRESCRIPTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 41 EUROPE OVER THE COUNTER (OTC) IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 42 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 43 EUROPE BRANDED IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 44 EUROPE GENERIC IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 45 EUROPE ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 46 EUROPE TOPICAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 47 EUROPE ORAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 48 EUROPE INJECTABLES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 49 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 50 EUROPE ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 51 EUROPE SOLUTION IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 52 EUROPE TABLETS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 53 EUROPE SPRAYS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 54 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 55 EUROPE ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 56 EUROPE FLEAS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 57 EUROPE TICKS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 58 EUROPE ROUND WORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 59 EUROPE HOOKWORMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 60 EUROPE EAR MITES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 61 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 62 EUROPE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 63 EUROPE ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 64 EUROPE COMPANION ANIMAL IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 65 EUROPE ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 66 EUROPE FARM ANIMALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 67 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 68 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 69 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 70 EUROPE VETERINARY CLINICS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 71 EUROPE ANIMAL FARMS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 72 EUROPE HOME CARE IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 73 EUROPE ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 74 EUROPE VETERINARY HOSPITALS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 75 EUROPE PET SHOPS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 76 EUROPE OTHERS IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 77 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 78 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 79 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 80 EUROPE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 81 EUROPE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 82 EUROPE DIRECT TENDER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 83 EUROPE OTHER IN ANIMAL PARASITICIDES MARKET, BY REGION, 2018-2033 (USD THOUSAND)
TABLE 84 EUROPE ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 85 EUROPE ANIMAL PARASITICIDES MARKET, BY COUNTRY, 2018-2033 (USD THOUSAND)
TABLE 86 USD THOUSAND
TABLE 87 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 88 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 89 EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 90 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 91 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 92 EUROPE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 93 EUROPE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 94 EUROPE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 95 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 96 EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 97 EUROPE ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 98 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 99 EUROPE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 100 EUROPE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 101 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 102 EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 103 EUROPE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 104 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 105 EUROPE ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 106 EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 107 EUROPE ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 108 EUROPE ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 109 EUROPE ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 110 EUROPE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 111 EUROPE ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 112 EUROPE ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 113 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 114 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 115 EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 116 EUROPE ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 117 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 118 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 119 EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 120 EUROPE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 121 USD THOUSAND
TABLE 122 GERMANY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 123 GERMANY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 124 GERMANY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNIT)
TABLE 125 GERMANY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 126 GERMANY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 127 GERMANY ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 128 GERMANY CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 129 GERMANY ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 130 GERMANY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 131 GERMANY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 132 GERMANY ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 133 GERMANY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 134 GERMANY BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 135 GERMANY IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 136 GERMANY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 137 GERMANY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 138 GERMANY ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 139 GERMANY ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 140 GERMANY ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 141 GERMANY ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 142 GERMANY ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 143 GERMANY ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 144 GERMANY ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 145 GERMANY ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 146 GERMANY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 147 GERMANY ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 148 GERMANY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 149 GERMANY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 150 GERMANY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNIT)
TABLE 151 GERMANY ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 152 GERMANY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 153 GERMANY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 154 GERMANY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNIT)
TABLE 155 GERMANY RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 156 USD THOUSAND
TABLE 157 U.K. ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 158 U.K. ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 159 U.K. ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 160 U.K. ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 161 U.K. ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 162 U.K. ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 163 U.K. CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 164 U.K. ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 165 U.K. ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 166 U.K. ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 167 U.K. ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 168 U.K. ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 169 U.K. BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 170 U.K. IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 171 U.K. ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 172 U.K. ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 173 U.K. ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 174 U.K. ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 175 U.K. ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 176 U.K. ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 177 U.K. ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 178 U.K. ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 179 U.K. ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 180 U.K. ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 181 U.K. ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 182 U.K. ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 183 U.K. ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 184 U.K. ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 185 U.K. ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 186 U.K. ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 187 U.K. ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 188 U.K. ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 189 U.K. ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 190 U.K. RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 191 USD THOUSNAD
TABLE 192 FRANCE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 193 FRANCE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 194 FRANCE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 195 FRANCE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 196 FRANCE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 197 FRANCE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 198 FRANCE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 199 FRANCE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 200 FRANCE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 201 FRANCE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 202 FRANCE ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 203 FRANCE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 204 FRANCE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 205 FRANCE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 206 FRANCE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 207 FRANCE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 208 FRANCE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 209 FRANCE ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 210 FRANCE ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 211 FRANCE ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 212 FRANCE ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 213 FRANCE ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 214 FRANCE ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 215 FRANCE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 216 FRANCE ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 217 FRANCE ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 218 FRANCE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 219 FRANCE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 220 FRANCE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 221 FRANCE ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 222 FRANCE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 223 FRANCE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 224 FRANCE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 225 FRANCE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 226 USD THOUSNAD
TABLE 227 ITALY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 228 ITALY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 229 ITALY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 230 ITALY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 231 ITALY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 232 ITALY ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 233 ITALY CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 234 ITALY ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 235 ITALY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 236 ITALY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 237 ITALY ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 238 ITALY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 239 ITALY BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 240 ITALY IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 241 ITALY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 242 ITALY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 243 ITALY ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 244 ITALY ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 245 ITALY ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 246 ITALY ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 247 ITALY ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 248 ITALY ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 249 ITALY ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 250 ITALY ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 251 ITALY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 252 ITALY ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 253 ITALY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 254 ITALY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 255 ITALY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 256 ITALY ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 257 ITALY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 258 ITALY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 259 ITALY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 260 ITALY RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 261 USD THOUSNAD
TABLE 262 SPAIN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 263 SPAIN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 264 SPAIN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 265 SPAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 266 SPAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 267 SPAIN ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 268 SPAIN CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 269 SPAIN ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 270 SPAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 271 SPAIN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 272 SPAIN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 273 SPAIN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 274 SPAIN BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 275 SPAIN IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 276 SPAIN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 277 SPAIN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 278 SPAIN ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 279 SPAIN ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 280 SPAIN ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 281 SPAIN ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 282 SPAIN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 283 SPAIN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 284 SPAIN ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 285 SPAIN ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 286 SPAIN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 287 SPAIN ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 288 SPAIN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 289 SPAIN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 290 SPAIN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 291 SPAIN ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 292 SPAIN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 293 SPAIN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 294 SPAIN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 295 SPAIN RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 296 USD THOUSNAD
TABLE 297 RUSSIA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 298 RUSSIA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 299 RUSSIA ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 300 RUSSIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 301 RUSSIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 302 RUSSIA ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 303 RUSSIA CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 304 RUSSIA ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 305 RUSSIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 306 RUSSIA ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 307 RUSSIA ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 308 RUSSIA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 309 RUSSIA BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 310 RUSSIA IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 311 RUSSIA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 312 RUSSIA ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 313 RUSSIA ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 314 RUSSIA ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 315 RUSSIA ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 316 RUSSIA ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 317 RUSSIA ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 318 RUSSIA ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 319 RUSSIA ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 320 RUSSIA ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 321 RUSSIA ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 322 RUSSIA ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 323 RUSSIA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 324 RUSSIA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 325 RUSSIA ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 326 RUSSIA ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 327 RUSSIA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 328 RUSSIA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 329 RUSSIA ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 330 RUSSIA RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 331 USD THOUSNAD
TABLE 332 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 333 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 334 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 335 SWITZERLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 336 SWITZERLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 337 SWITZERLAND ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 338 SWITZERLAND CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 339 SWITZERLAND ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 340 SWITZERLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 341 SWITZERLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 342 SWITZERLAND ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 343 SWITZERLAND ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 344 SWITZERLAND BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 345 SWITZERLAND IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 346 SWITZERLAND ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 347 SWITZERLAND ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 348 SWITZERLAND ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 349 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 350 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 351 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 352 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 353 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 354 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 355 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 356 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 357 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 358 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 359 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 360 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 361 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 362 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 363 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 364 SWITZERLAND ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 365 SWITZERLAND RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 366 USD THOUSNAD
TABLE 367 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 368 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 369 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 370 NETHERLANDS ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 371 NETHERLANDS ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 372 NETHERLANDS ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 373 NETHERLANDS CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 374 NETHERLANDS ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 375 NETHERLANDS ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 376 NETHERLANDS ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 377 NETHERLANDS ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 378 NETHERLANDS ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 379 NETHERLANDS BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 380 NETHERLANDS IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 381 NETHERLANDS ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 382 NETHERLANDS ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 383 NETHERLANDS ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 384 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 385 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 386 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 387 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 388 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 389 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 390 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 391 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 392 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 393 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 394 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 395 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 396 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 397 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 398 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 399 NETHERLANDS ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 400 NETHERLANDS RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 401 USD THOUSNAD
TABLE 402 TURKEY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 403 TURKEY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 404 TURKEY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 405 TURKEY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 406 TURKEY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 407 TURKEY ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 408 TURKEY CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 409 TURKEY ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 410 TURKEY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 411 TURKEY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 412 TURKEY ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 413 TURKEY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 414 TURKEY BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 415 TURKEY IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 416 TURKEY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 417 TURKEY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 418 TURKEY ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 419 TURKEY ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 420 TURKEY ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 421 TURKEY ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 422 TURKEY ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 423 TURKEY ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 424 TURKEY ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 425 TURKEY ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 426 TURKEY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 427 TURKEY ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 428 TURKEY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 429 TURKEY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 430 TURKEY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 431 TURKEY ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 432 TURKEY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 433 TURKEY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 434 TURKEY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 435 TURKEY RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 436 USD THOUSNAD
TABLE 437 BELGIUM ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 438 BELGIUM ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 439 BELGIUM ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 440 BELGIUM ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 441 BELGIUM ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 442 BELGIUM ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 443 BELGIUM CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 444 BELGIUM ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 445 BELGIUM ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 446 BELGIUM ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 447 BELGIUM ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 448 BELGIUM ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 449 BELGIUM BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 450 BELGIUM IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 451 BELGIUM ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 452 BELGIUM ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 453 BELGIUM ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 454 BELGIUM ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 455 BELGIUM ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 456 BELGIUM ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 457 BELGIUM ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 458 BELGIUM ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 459 BELGIUM ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 460 BELGIUM ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 461 BELGIUM ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 462 BELGIUM ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 463 BELGIUM ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 464 BELGIUM ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 465 BELGIUM ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 466 BELGIUM ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 467 BELGIUM ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 468 BELGIUM ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 469 BELGIUM ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 470 BELGIUM RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 471 USD THOUSNAD
TABLE 472 DENMARK ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 473 DENMARK ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 474 DENMARK ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 475 DENMARK ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 476 DENMARK ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 477 DENMARK ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 478 DENMARK CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 479 DENMARK ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 480 DENMARK ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 481 DENMARK ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 482 DENMARK ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 483 DENMARK ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 484 DENMARK BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 485 DENMARK IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 486 DENMARK ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 487 DENMARK ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 488 DENMARK ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 489 DENMARK ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 490 DENMARK ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 491 DENMARK ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 492 DENMARK ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 493 DENMARK ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 494 DENMARK ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 495 DENMARK ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 496 DENMARK ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 497 DENMARK ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 498 DENMARK ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 499 DENMARK ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 500 DENMARK ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 501 DENMARK ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 502 DENMARK ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 503 DENMARK ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 504 DENMARK ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 505 DENMARK RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 506 USD THOUSNAD
TABLE 507 SWEDEN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 508 SWEDEN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 509 SWEDEN ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 510 SWEDEN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 511 SWEDEN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 512 SWEDEN ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 513 SWEDEN CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 514 SWEDEN ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 515 SWEDEN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 516 SWEDEN ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 517 SWEDEN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 518 SWEDEN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 519 SWEDEN BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 520 SWEDEN IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 521 SWEDEN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 522 SWEDEN ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 523 SWEDEN ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 524 SWEDEN ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 525 SWEDEN ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 526 SWEDEN ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 527 SWEDEN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 528 SWEDEN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 529 SWEDEN ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 530 SWEDEN ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 531 SWEDEN ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 532 SWEDEN ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 533 SWEDEN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 534 SWEDEN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 535 SWEDEN ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 536 SWEDEN ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 537 SWEDEN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 538 SWEDEN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 539 SWEDEN ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 540 SWEDEN RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 541 USD THOUSNAD
TABLE 542 NORWAY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 543 NORWAY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 544 NORWAY ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 545 NORWAY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 546 NORWAY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 547 NORWAY ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 548 NORWAY CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 549 NORWAY ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 550 NORWAY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 551 NORWAY ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 552 NORWAY ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 553 NORWAY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 554 NORWAY BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 555 NORWAY IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 556 NORWAY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 557 NORWAY ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 558 NORWAY ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 559 NORWAY ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 560 NORWAY ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 561 NORWAY ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 562 NORWAY ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 563 NORWAY ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 564 NORWAY ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 565 NORWAY ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 566 NORWAY ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 567 NORWAY ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 568 NORWAY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 569 NORWAY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 570 NORWAY ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 571 NORWAY ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 572 NORWAY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 573 NORWAY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 574 NORWAY ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 575 NORWAY RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 576 USD THOUSNAD
TABLE 577 FINLAND ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 578 FINLAND ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 579 FINLAND ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 580 FINLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 581 FINLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 582 FINLAND ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 583 FINLAND CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 584 FINLAND ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 585 FINLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 586 FINLAND ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 587 FINLAND ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 588 FINLAND ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 589 FINLAND BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 590 FINLAND IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 591 FINLAND ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 592 FINLAND ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 593 FINLAND ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 594 FINLAND ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 595 FINLAND ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 596 FINLAND ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 597 FINLAND ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 598 FINLAND ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 599 FINLAND ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 600 FINLAND ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 601 FINLAND ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 602 FINLAND ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 603 FINLAND ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 604 FINLAND ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 605 FINLAND ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 606 FINLAND ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 607 FINLAND ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 608 FINLAND ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 609 FINLAND ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 610 FINLAND RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 611 USD THOUSNAD
TABLE 612 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (USD THOUSAND)
TABLE 613 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (THOUSAND UNITS)
TABLE 614 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT, 2018-2033 (ASP IN USD/UNITS)
TABLE 615 REST OF EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 616 REST OF EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 617 REST OF EUROPE ORGANOCHLORINES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 618 REST OF EUROPE CARBAMATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 619 REST OF EUROPE ORGANOPHOSPHATES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 620 REST OF EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 621 REST OF EUROPE ECTOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 622 REST OF EUROPE ANIMAL PARASITICIDES MARKET, 2018-2033 (USD THOUSAND)
TABLE 623 REST OF EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 624 REST OF EUROPE BENZIMIDAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 625 REST OF EUROPE IMIDAZOTHIAZOLES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 626 REST OF EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM , 2018-2033 (USD THOUSAND)
TABLE 627 REST OF EUROPE ENDOPARASITICIDES IN ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 628 REST OF EUROPE ENDECTOCIDES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
TABLE 629 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG CLASS, 2018-2033 (USD THOUSAND)
TABLE 630 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY MODE OF PURCHASE, 2018-2033 (USD THOUSAND)
TABLE 631 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DRUG TYPE, 2018-2033 (USD THOUSAND)
TABLE 632 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY ROUTE OF ADMINISTRATION, 2018-2033 (USD THOUSAND)
TABLE 633 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DOSAGE FORM, 2018-2033 (USD THOUSAND)
TABLE 634 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DISEASE TYPE , 2018-2033 (USD THOUSAND)
TABLE 635 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY ANIMAL TYPE, 2018-2033 (USD THOUSAND)
TABLE 636 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY COMPANION ANIMAL, 2018-2033 (USD THOUSAND)
TABLE 637 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY FARM ANIMALSL, 2018-2033 (USD THOUSAND)
TABLE 638 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (USD THOUSAND)
TABLE 639 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (THOUSAND UNITS)
TABLE 640 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY END USER, 2018-2033 (ASP IN USD/UNITS)
TABLE 641 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY VETERINARY HOSPITALS, 2018-2033 (USD THOUSAND)
TABLE 642 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (USD THOUSAND)
TABLE 643 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (THOUSAND UNITS)
TABLE 644 REST OF EUROPE ANIMAL PARASITICIDES MARKET, BY DISTRIBUTION CHANNEL, 2018-2033 (ASP IN USD/UNITS)
TABLE 645 REST OF EUROPE RETAIL SALES IN ANIMAL PARASITICIDES MARKET, BY TYPE, 2018-2033 (USD THOUSAND)
List of Figure
FIGURE 1 EUROPE ANIMAL PARASITICIDES MARKET: SEGMENTATION
FIGURE 2 EUROPE ANIMAL PARASITICIDES MARKET: DATA TRIANGULATION
FIGURE 3 EUROPE ANIMAL PARASITICIDES MARKET: DROC ANALYSIS
FIGURE 4 EUROPE ANIMAL PARASITICIDES MARKET: EUROPE VS REGIONAL MARKET ANALYSIS
FIGURE 5 EUROPE ANIMAL PARASITICIDES MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 EUROPE ANIMAL PARASITICIDES MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 EUROPE ANIMAL PARASITICIDES MARKET: DBMR MARKET POSITION GRID
FIGURE 8 EUROPE ANIMAL PARASITICIDES MARKET: VENDOR SHARE ANALYSIS
FIGURE 9 EUROPE ANIMAL PARASITICIDES MARKET: MULTIVARIVATE MODELING
FIGURE 10 EUROPE ANIMAL PARASITICIDES MARKET: PRODUCT TYPE TIMELINE CURVE
FIGURE 11 EUROPE ANIMAL PARASITICIDES MARKET: APPLICATION COVERAGE GRID
FIGURE 12 EUROPE ANIMAL PARASITICIDES MARKET: SEGMENTATION
FIGURE 13 THREE SEGMENTS COMPRISE THE EUROPE ANIMAL PARASITICIDES MARKET, BY PRODUCT (2025)
FIGURE 14 EUROPE ANIMAL PARASITICIDES MARKET: EXECUTIVE SUMMARY
FIGURE 15 INCREASING BURDEN OF VECTOR-BORNE PARASITES AFFECTING ANIMAL HEALTH IS EXPECTED TO DRIVE THE EUROPE ANIMAL PARASITICIDES MARKET DURING THE FORECAST PERIOD OF 2026 TO 2033.
FIGURE 16 ECTOPARASITICIDES IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE EUROPE ANIMAL PARASITICIDES MARKET IN 2026 & 2033
FIGURE 17 STRATEGIC DECISIONS
FIGURE 18 PORTER’S FIVE FORCES ANALYSIS
FIGURE 19 PESTEL ANALYSIS
FIGURE 20 TOP ENTITIES BASED ON R&D GLANCE FOR EUROPE ANIMAL PARASITICIDES MARKET
FIGURE 21 R & D ANALYSIS
FIGURE 22 DROC ANALYSIS
FIGURE 23 EUROPE ANIMAL PARASITICIDES MARKET : BY PRODUCT, 2025
FIGURE 24 EUROPE ANIMAL PARASITICIDES MARKET : BY PRODUCT, 2026 TO 2033 (USD THOUSAND)
FIGURE 25 EUROPE ANIMAL PARASITICIDES MARKET : BY PRODUCT, CAGR (2026- 2033)
FIGURE 26 EUROPE ANIMAL PARASITICIDES MARKET : BY PRODUCT, LIFELINE CURVE
FIGURE 27 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, 2025
FIGURE 28 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, 2026 TO 2033 (USD THOUSAND)
FIGURE 29 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG CLASS, CAGR (2026- 2033)
FIGURE 30 EUROPE ANIMAL PARASITICIDES MARKET: BY P DRUG CLASS, LIFELINE CURVE
FIGURE 31 EUROPE ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , 2025
FIGURE 32 EUROPE ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , 2026 TO 2033 (USD THOUSAND)
FIGURE 33 EUROPE ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , CAGR (2026- 2033)
FIGURE 34 EUROPE ANIMAL PARASITICIDES MARKET : BY MODE OF PURCHASE , LIFELINE CURVE
FIGURE 35 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, 2025
FIGURE 36 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, TO 2033 (USD THOUSAND)
FIGURE 37 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, CAGR (2026- 2033)
FIGURE 38 EUROPE ANIMAL PARASITICIDES MARKET: BY DRUG TYPE, LIFELINE CURVE
FIGURE 39 EUROPE ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, 2025
FIGURE 40 EUROPE ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, 2026 TO 2033 (USD THOUSAND)
FIGURE 41 EUROPE ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, CAGR (2026- 2033)
FIGURE 42 EUROPE ANIMAL PARASITICIDES MARKET : BY ROUTE OF ADMINISTRATION, LIFELINE CURVE
FIGURE 43 EUROPE ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, 2025
FIGURE 44 EUROPE ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, 2026 TO 2033 (USD THOUSAND)
FIGURE 45 EUROPE ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, CAGR (2026- 2033)
FIGURE 46 EUROPE ANIMAL PARASITICIDES MARKET : BY DOSAGE FORM, LIFELINE CURVE
FIGURE 47 EUROPE ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, 2025
FIGURE 48 EUROPE ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, 2026 TO 2033 (USD THOUSAND)
FIGURE 49 EUROPE ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, CAGR (2026- 2033)
FIGURE 50 EUROPE ANIMAL PARASITICIDES MARKET: BY DISEASE TYPE, LIFELINE CURVE
FIGURE 51 EUROPE ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, 2025
FIGURE 52 EUROPE ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, 2026 TO 2033 (USD THOUSAND)
FIGURE 53 EUROPE ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, CAGR (2026- 2033)
FIGURE 54 EUROPE ANIMAL PARASITICIDES MARKET: BY ANIMAL TYPE, LIFELINE CURVE
FIGURE 55 EUROPE ANIMAL PARASITICIDES MARKET: BY END USER, 2025
FIGURE 56 EUROPE ANIMAL PARASITICIDES MARKET: BY END USER, 2026 TO 2033 (USD THOUSAND)
FIGURE 57 EUROPE ANIMAL PARASITICIDES MARKET: BY END USER, CAGR (2026- 2033)
FIGURE 58 EUROPE ANIMAL PARASITICIDES MARKET: BY END USER, LIFELINE CURVE
FIGURE 59 EUROPE ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, 2025
FIGURE 60 EUROPE ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, 2026 TO 2033 (USD THOUSAND)
FIGURE 61 EUROPE ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, CAGR (2026- 2033)
FIGURE 62 EUROPE ANIMAL PARASITICIDES MARKET: BY DISTRIBUTION CHANNEL, LIFELINE CURVE
FIGURE 63 EUROPE ANIMAL PARASITICIDES MARKET: SNAPSHOT (2025)
FIGURE 64 EUROPE ANIMAL PARASITICIDES MARKET: COMPANY SHARE 2025 (%)
FIGURE 65 EUROPE ANIMAL PARASITICIDES MARKET-, SNAPSHOT (2025)
Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.
The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.
Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.
